ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Alopecia Patent Allowed in Australia and Japan
|
|
occhi.di.falco
|
27 |
7.0K |
6 |
25/04/20 |
25/04/20 |
ASX - By Stock
|
27
|
7.0K
|
6
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Alopecia Patent Allowed in Australia and Japan
|
|
occhi.di.falco
|
27 |
7.0K |
3 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
27
|
7.0K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Alopecia Patent Allowed in Australia and Japan
|
|
occhi.di.falco
|
27 |
7.0K |
3 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
27
|
7.0K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Alopecia Patent Allowed in Australia and Japan
|
|
occhi.di.falco
|
27 |
7.0K |
7 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
27
|
7.0K
|
7
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
occhi.di.falco
|
1.2K |
410K |
3 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
1.2K
|
410K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
occhi.di.falco
|
1.2K |
410K |
0 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
1.2K
|
410K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
QVC Germany / Europe
|
|
occhi.di.falco
|
5 |
1.6K |
1 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
5
|
1.6K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Wondfo Response
|
|
occhi.di.falco
|
23 |
6.1K |
2 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
23
|
6.1K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
occhi.di.falco
|
1.2K |
410K |
0 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
1.2K
|
410K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
occhi.di.falco
|
145 |
33K |
0 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
145
|
33K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
occhi.di.falco
|
145 |
33K |
6 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
145
|
33K
|
6
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
occhi.di.falco
|
145 |
33K |
6 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
145
|
33K
|
6
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
occhi.di.falco
|
394 |
122K |
4 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
394
|
122K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Wondfo Response
|
|
occhi.di.falco
|
23 |
6.1K |
7 |
21/04/20 |
21/04/20 |
ASX - By Stock
|
23
|
6.1K
|
7
|
|
ASX - By Stock
|
AN1 |
Re:
Wondfo Response
|
|
occhi.di.falco
|
23 |
6.1K |
5 |
21/04/20 |
21/04/20 |
ASX - By Stock
|
23
|
6.1K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
occhi.di.falco
|
394 |
122K |
4 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
394
|
122K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
occhi.di.falco
|
394 |
122K |
1 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
394
|
122K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
occhi.di.falco
|
394 |
122K |
1 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
394
|
122K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
occhi.di.falco
|
394 |
122K |
0 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
394
|
122K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
occhi.di.falco
|
394 |
122K |
1 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
394
|
122K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
occhi.di.falco
|
394 |
122K |
9 |
19/04/20 |
19/04/20 |
ASX - By Stock
|
394
|
122K
|
9
|
|
ASX - By Stock
|
AN1 |
Emirates & Covid-19 Rapid Testing
|
|
occhi.di.falco
|
0 |
436 |
8 |
19/04/20 |
19/04/20 |
ASX - By Stock
|
0
|
436
|
8
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
occhi.di.falco
|
394 |
122K |
10 |
18/04/20 |
18/04/20 |
ASX - By Stock
|
394
|
122K
|
10
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
occhi.di.falco
|
394 |
122K |
2 |
18/04/20 |
18/04/20 |
ASX - By Stock
|
394
|
122K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
occhi.di.falco
|
394 |
122K |
15 |
18/04/20 |
18/04/20 |
ASX - By Stock
|
394
|
122K
|
15
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
occhi.di.falco
|
394 |
122K |
12 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
394
|
122K
|
12
|
|
ASX - By Stock
|
AN1 |
Re:
PM Says Agressive Testing is the Way Out
|
|
occhi.di.falco
|
10 |
2.6K |
3 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
10
|
2.6K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
PM Says Agressive Testing is the Way Out
|
|
occhi.di.falco
|
10 |
2.6K |
11 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
10
|
2.6K
|
11
|
|
ASX - By Stock
|
AN1 |
Re:
Top 20 Shareholder Listing – End Q2 2020
|
|
occhi.di.falco
|
20 |
5.4K |
0 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
20
|
5.4K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
PM Says Agressive Testing is the Way Out
|
|
occhi.di.falco
|
10 |
2.6K |
4 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
10
|
2.6K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Top 20 Shareholder Listing – End Q2 2020
|
|
occhi.di.falco
|
20 |
5.4K |
1 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
20
|
5.4K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
PM Says Agressive Testing is the Way Out
|
|
occhi.di.falco
|
10 |
2.6K |
2 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
10
|
2.6K
|
2
|
|
ASX - By Stock
|
AN1 |
PM Says Agressive Testing is the Way Out
|
|
occhi.di.falco
|
10 |
2.6K |
4 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
10
|
2.6K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Top 20 Shareholder Listing – End Q2 2020
|
|
occhi.di.falco
|
20 |
5.4K |
2 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
20
|
5.4K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
occhi.di.falco
|
394 |
122K |
3 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
394
|
122K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Proposed issue of Securities - CDY
|
|
occhi.di.falco
|
56 |
13K |
2 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
56
|
13K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Proposed issue of Securities - CDY
|
|
occhi.di.falco
|
56 |
13K |
11 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
56
|
13K
|
11
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
occhi.di.falco
|
394 |
122K |
7 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
394
|
122K
|
7
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
occhi.di.falco
|
394 |
122K |
9 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
394
|
122K
|
9
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
occhi.di.falco
|
394 |
122K |
13 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
394
|
122K
|
13
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
occhi.di.falco
|
394 |
122K |
4 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
394
|
122K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
occhi.di.falco
|
1.2K |
410K |
0 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
1.2K
|
410K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
occhi.di.falco
|
1.2K |
410K |
7 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
1.2K
|
410K
|
7
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
occhi.di.falco
|
1.2K |
410K |
5 |
13/04/20 |
13/04/20 |
ASX - By Stock
|
1.2K
|
410K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
occhi.di.falco
|
1.2K |
410K |
12 |
13/04/20 |
13/04/20 |
ASX - By Stock
|
1.2K
|
410K
|
12
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
occhi.di.falco
|
1.2K |
410K |
6 |
13/04/20 |
13/04/20 |
ASX - By Stock
|
1.2K
|
410K
|
6
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
occhi.di.falco
|
1.2K |
410K |
8 |
13/04/20 |
13/04/20 |
ASX - By Stock
|
1.2K
|
410K
|
8
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
occhi.di.falco
|
1.2K |
410K |
0 |
13/04/20 |
13/04/20 |
ASX - By Stock
|
1.2K
|
410K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
occhi.di.falco
|
1.2K |
410K |
4 |
13/04/20 |
13/04/20 |
ASX - By Stock
|
1.2K
|
410K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
occhi.di.falco
|
1.2K |
410K |
0 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
1.2K
|
410K
|
0
|
|